Search Thermo Fisher Scientific
- Contact Us
- Quick Order
-
Don't have an account ? Create Account
Search Thermo Fisher Scientific
2′ Modified RNA Phosphoramidites |
Our comprehensive 2′ modified RNA phosphoramidites portfolio is uniquely designed for oligonucleotide therapeutic development and manufacturing. Seamlessly scale up your synthesis of siRNA and ASO for RNA therapeutics from early-stage development to commercialization with the comprehensive supply of Thermo Scientifics phosphorarmidites.
Modifications at the 2′ position of the ribose ring are commonly used to help increase oligonucleotide stability and improve resistance to nuclease activity in vivo. Our 2'-modified RNA phosphoramidites are manufactured to precise standards to help ensure quality, consistency, and reliability for efficient synthesis of nucleic acid-based therapeutics. Multiple quality grades of TheraPure, standard, or fast deprotect phosphoramidites are available to choose from.
TheraPure and standard grades 2′-OMe phosphoramidites are available for oligo synthesis of diagnostics or therapeutics manufacturing. For faster deprotection times, consider reviewing the PAC chemistries in combination with 2'-OMe U (no base protection) and Ac-rC.
Modification | 2'-OMe phosphoramidites | |||||
Common applications | siRNA (small interfering RNA) | Diagnostics | ||||
Quality grades |
| Fast deprotect | ||||
Featuring quality attribute |
| Allow the removal of base-protecting groups under mild or accelerated conditions | ||||
Bz-A | U | G | C | PAC-A | iPrPAC-G | |
Applied Biosystems/AKTA Synthesizer | 27-2042-04 | 27-2044-04 | 27-2046-04 | 27-2043-04 | 27-1822-02 | 27-1826-02 |
Expedite Synthesizer | 27-2042-10 | 27-2044-10 | 27-2046-10 | 27-2043-10 | 27-1822-10 | 27-1826-10 |
MerMade Synthesizer | Custom orders are available. | 27-1822-11 | 27-1826-11 |
Quality attributes of 2′-OMe phosphoramidites are presented in the table below.
Click images to enlarge
2′-OMe-Bz-A-CEP | 2′-OMe-U-CEP | 2′-OMe-iBu-G-CEP | 2′-OMe-Ac-C-CEP | |
---|---|---|---|---|
TheraPure grade Cat. No. | 27-2042 | 27-2044 | 27-2046 | 27-2043 |
Standard grade Cat. No. | 27-1842 | 27-1825 | 27-1846 | 27-1823 |
Formula | C48H54N7O8P | C40H56N7O9P | C45H56N7O9P | C42H52N5O9P |
Molecular weight | 887.97 g/mol | 760.8 g/mol | 869.9 g/mol | 801.86 g/mol |
CAS # | 110782-31-5 | 110764-79-9 | 150780-67-9 | 199593-09-4 |
Appearance | Color intensity must not exceed Pantone #P1-4U or #P4-2U | |||
HPLC purity (TheraPure phosphoramidites) | ≥ 98.0% | (>99%) * | |||
M-11 Impurity | ≤ 0.01% | |||
31P NMR purity (TheraPure phosphoramidites) | ≥ 98.0% | (>99%) * | |||
Shipping / Storage condition | Ambient / –20 °C | |||
Water content | ≤ 0.2% (KF Method) | |||
Material Origin | Non-animal source (no TSE/BSE risk) |
Available 2′-OMe phosphoramidites in TheraPure or standard grades and are compatible with the following oligonucleotide synthesizers:
Compatible products are in amber bottles with serum vial neck style as ready-to-ship catalog SKU for your siRNA and ASO synthesis.
Available catalog SKUs are supplied in 30 mL amber bottle with a 20-400 finish neck style. Compatible with the Expedite synthesizer for antisense, siRNA, aptamer, or gRNA-based research.
Utilize PAC-A and iPrPAC-G with Ac-C and U to minimize deprotection times. Acetylated amidites (such as Ac-G, SY5400) are excellent for shortening deprotection times for longmers.
2′-OMe-PAC-A-CEP | 2′-OMe-iPrPAC-G-CEP | TheraPure 2'-OMe-Ac-G-CEP | ||
---|---|---|---|---|
Cat. No. | 27-1822 | 27-1826 | SY5400 | |
Formula | C49H56N7O9P | C52H62N7O10P | C43H52N7O9P | |
Molecular weight | 918.0 g/mol | 976.1 g/mol | 841.9 g/mol | |
CAS # | 128219-82-9 | NA | 909033-40-5 | |
HPLC purity | ≥ 98.0% | ≥ 98.0% | ≥ 99% | |
31P NMR purity | ≥ 98.0% | ≥ 98.0% | ≥ 99% | |
Hazardous | No | |||
Shipping / Storage condition | Ambient / –20 °C | |||
Material Origin | Non-animal source (no TSE/BSE risk) |
C52H62N7O10P |
2′-OMe modified RNA phosphoramidites are compatible with the following oligonucleotide synthesizers:
Compatible catalog products are ready-to-ship in amber bottles with serum vial neck style.
Available catalog SKUs are supplied in 30 mL amber bottle with a 20-400 finish neck style.
Compatible products are available to ship in a 30 mL amber bottle with a 28-400 finish neck style.
Synthesizing RNA oligonucleotides using 2′-Fluoro Bz A, iBu G, Ac C, and U phosphoramidites increases the thermal stability of RNA duplexes and increases the nuclease resistance of single-stranded RNA. These phosphoramidites can be incorporated into custom siRNA oligonucleotides for use in gene-targeting and suppression studies.
Modifications | 2'-Fluoro phosphoramidites | ||||
Common applications | siRNA (small interfering RNA) | ||||
Quality grades | TheraPure | Standard | |||
Featuring quality attribute | Maximal QC and analytical testing supported by documentation | Traditional base protection method. Highly reliable for routine oligo synthesis | |||
Ac-C | U | Ac-G | Bz-A | iBu-G | |
Applied Biosystems/AKTA Synthesizer | 27-1604-02 | 27-1602-02 | Custom orders are available.
| 27-1601.02 | 27-1607-02 |
Expedite Synthesizer | 27-1604-09 | 27-1602-09 | 27-1601-09 | 27-1607-09 | |
MerMade Synthesizer | 27-1604-12 |
| 27-1601.12 | 27-1607-12 |
Click images to enlarge
2′-F-Ac-C-CEP | 2′-F-U-CEP | 2'-F-Ac-G-CEP | 2′-F-Bz-A-CEP | 2′-F-iBu-G-CEP | |
---|---|---|---|---|---|
Quality grade | Therapure | Standard | |||
Cat. No. | 27-1604 | 27-1602 | SY5410* | 27-1601 | 27-1607 |
Formula | C41H49N5FO8P | C39H46FN4O8P | C42H49FN7O8P | C47H51FN7O7P | C44H53FN7O8P |
Molecular weight | 798.8 g/mol | 748.8 g/mol | 829.87 g/mol | 875.92 g/mol | 857.4 g/mol |
CAS # | 159414-99-0 | 146954-75-8 | N/A | N/A | 144089-97-4 |
Residual Solvent | ≤ 3.0% total % by weight solvent | N/A | |||
Appearance | White to light yellow powder | ||||
HPLC purity* | >98% | ||||
31P NMR purity* | >98% | ||||
Solution Clarity | Free from undissolved particulate at 0.2 M solution in ACN | ||||
Shipping / Storage condition | Ambient / –20 C | ||||
Water content | ≤ 0.3% | ||||
Material Origin | Non-animal source (no TSE/BSE risk) |
2′-Fluoro modified RNA phosphoramidites are compatible with the following oligonucleotide synthesizers:
Order compatible products in amber bottles with serum vial neck style. Available in TheraPure and standard quality grades.
Available catalog SKUs are supplied in 30 mL amber bottle with a 20-400 finish neck style. Choose from quality grades of TheraPure or standard.
Catalog SKUs available that are compatible with the MerMade synthesizer in a 30 mL amber bottle with a 28-400 finish neck style.
RNA oligonucleotides synthesized using 2′-MOE modifications phosphoramidites have shown to be more nuclease resistant, with lower toxicity, and slightly increased hybridization affinities, making them well suited for therapeutic in vivo applications, such as antisense (ASO), siRNA, and aptamers.
Modifications | 2'-MOE phosphoramidites | |||
Common applications | ASO (antisense oligonucleotides) | |||
Quality grades | TheraPure | |||
Featuring quality attribute | Maximal QC testing to help ensure impurities and residual solvents are within the stringent requirement for oligo therapeutics | |||
A | 5mC | G | T | |
Applied Biosystems/AKTA Synthesizer | 27-1019-02 | 27-1020-02 | 27-1022-02 | 27-1021-02 |
Expedite Synthesizer | Custom orders are available. | |||
MerMade Synthesizer | 27-1019-11 | 27-1020-11 | 27-1022-11 | 27-1021-11 |
Click images to enlarge
2′-MOE-A CEP | 2′-MOE-5mC CEP | 2′-MOE-G CEP | 2′-MOE-T CEP | |
---|---|---|---|---|
Quality grade | TheraPure | TheraPure | TheraPure | TheraPure |
Cat. No. | 27-1019 | 27-1020 | 27-1022 | 27-1021 |
Formula | C50H58N7O9P | C50H60N5O10P | C47H60N7O10P | C43H55N4O10P |
Molecular weight | 932.03 g/mol | 922.0 g/mol | 914.01 g/mol | 819.0 g/mol |
CAS # | 251647-53-7 | 163759-94-2 | 251647-55-9 | 163878-63-5 |
Solution clarity | Free from undissolved particulate at 0.2 M solution in ACN | |||
HPLC purity* | ≥99% | |||
31P NMR purity* | ≥99% | |||
Shipping / Storage condition | Ambient / –20°C | |||
Water content | ≤0.3% (by KF Method) | |||
Total residual solvents | ≤4.0% | |||
Material origin | Non-animal source (no TSE/BSE risk) |
TheraPure RNA phosphoramidites with 2′-MOE modifications are compatible with the following oligonucleotide synthesizers:
Compatible catalog products of 1 g or 5 g are ready-to-ship in amber bottles with serum vial neck style.
Catalog SKUs compatible to MerMade synthesizer are ready-to-ship in 30 mL amber bottle with a 28-400 finish neck style. Sizing options of 1 g or 2 g are available to choose from.
Speak with a technical specialist about support available for the oligonucleotide manufacturing process development of your unique projects.
Access webinars, videos, articles, and more to optimize your success in oligonucleotide synthesis for diagnostic and therapeutic manufacturing process development.
Browse the educational assets related to raw materials selection, process development using in vitro transcription, scale-up synthesis, and the latest trends in mRNA production.
For Research Use Only. Not for use in diagnostic procedures.